Neuberger Berman Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$30.1M Sell
3,723,328
-11,755
-0.3% -$95.1K 0.02% 555
2025
Q1
$31.4M Sell
3,735,083
-27,664
-0.7% -$233K 0.03% 525
2024
Q4
$29.8M Sell
3,762,747
-24,918
-0.7% -$197K 0.02% 564
2024
Q3
$31.5M Buy
3,787,665
+219,312
+6% +$1.82M 0.02% 540
2024
Q2
$22.7M Sell
3,568,353
-352,622
-9% -$2.24M 0.02% 609
2024
Q1
$23.8M Buy
3,920,975
+179,968
+5% +$1.09M 0.02% 609
2023
Q4
$22.7M Sell
3,741,007
-84,603
-2% -$514K 0.02% 592
2023
Q3
$16.2M Buy
3,825,610
+77,671
+2% +$328K 0.01% 640
2023
Q2
$11.5M Buy
3,747,939
+65,312
+2% +$201K 0.01% 725
2023
Q1
$5.11M Buy
3,682,627
+192,972
+6% +$268K ﹤0.01% 873
2022
Q4
$6.94M Buy
3,489,655
+1,736
+0% +$3.46K 0.01% 812
2022
Q3
$7.06M Buy
3,487,919
+260,027
+8% +$527K 0.01% 807
2022
Q2
$10.3M Buy
3,227,892
+29,524
+0.9% +$94.1K 0.01% 743
2022
Q1
$13.3M Sell
3,198,368
-70,180
-2% -$293K 0.01% 756
2021
Q4
$15.6M Sell
3,268,548
-43,626
-1% -$208K 0.01% 744
2021
Q3
$17.5M Sell
3,312,174
-53,907
-2% -$284K 0.02% 717
2021
Q2
$17.1M Sell
3,366,081
-68,185
-2% -$347K 0.02% 736
2021
Q1
$23M Sell
3,434,266
-185,556
-5% -$1.24M 0.02% 648
2020
Q4
$16.5M Sell
3,619,822
-65,655
-2% -$299K 0.02% 695
2020
Q3
$14.3M Sell
3,685,477
-53,707
-1% -$208K 0.02% 656
2020
Q2
$17.8M Sell
3,739,184
-90,902
-2% -$433K 0.02% 593
2020
Q1
$13.3M Buy
3,830,086
+312,170
+9% +$1.08M 0.02% 593
2019
Q4
$16.9M Sell
3,517,916
-49,283
-1% -$237K 0.02% 635
2019
Q3
$10.4M Buy
3,567,199
+982,549
+38% +$2.85M 0.01% 710
2019
Q2
$18.5M Buy
2,584,650
+874,651
+51% +$6.27M 0.02% 618
2019
Q1
$24.2M Buy
1,709,999
+28,747
+2% +$407K 0.03% 556
2018
Q4
$22.8M Sell
1,681,252
-38,546
-2% -$522K 0.03% 525
2018
Q3
$38.2M Sell
1,719,798
-56,095
-3% -$1.24M 0.04% 461
2018
Q2
$29.1M Buy
+1,775,893
New +$29.1M 0.03% 543